Wednesday, January 29, 2020


Knight Therapeutics Inc
(TSX: GUD.TO) Add to Watchlist
unch (unch)
as of Jan 28, 2020

Last 7.91
Change unch (unch)
Open 7.91
Prev. Close 7.91
Today's Range
7.89 7.96
52wk Range
7.10 8.88
Volume 561,745
Avg Volume 223,692

Recent Headlines
Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company and Debiopharm , a swiss-based, global biopharmaceutical company, today announced that they have entered into an exclusive agreement that grants Knight the rights to commercialize Trelstar(R) (tr  (full story)
KHTRF: 6.0033 (+0.1208), GUD.TO: 7.91 (unch)
Knight Therapeutics Inc. (TSX: GUD) ("Knight") a leading pan-American (ex-USA) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Financial Officer, is scheduled to present at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 4:30 PM PST at  (full story)
KHTRF: 6.0033 (+0.1208), GUD.TO: 7.91 (unch)
Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. ("Knight" or "Offeror") today announced that, further to its acquisition of a controlling interest (the "Transfer of Control") in Biotoscana Investments S.A. ("GBT" or "Company"), it has submitted to B3 S.A. - Br  (full story)
KHTRF: 6.0033 (+0.1208), GUD.TO: 7.91 (unch)
Transformational acquisition establishes Knight as a premiere pan-American (ex-US) specialty pharma company  (full story)
KHTRF: 6.0033 (+0.1208), GUD.TO: 7.91 (unch)
Knight Therapeutics Inc. (TSX: GUD) ("Knight") and TherapeuticsMD, Inc. (NASDAQ: TXMD) ("TherapeuticsMD") announced today that Knight's New Drug Submission (NDS) for BIJUVA(R) has been accepted for review by Health Canada. BIJUVA, estradiol and progesterone capsules, is licensed by Knight from Thera  (full story)
KHTRF: 6.0033 (+0.1208), GUD.TO: 7.91 (unch), TXMD: 2.52 (+0.01)
Performance Comparison
Name Today 3-Month 1-Year
GUD.TO unch +2.33% -1.37%
$TXCX +0.33% +3.12% +13.80%
$TXCI +0.38% +2.90% +13.57%
DJIA +0.66% +3.38% +17.10%
S&P 500 +1.01% +5.89% +23.92%

Key Statistics
Annual EPS 0.15
Dividend & Yield -- (--)
P/E Ratio 51.70
Market Capitalization, $K 1,072,826
Weighted Alpha +2.70
Standard Deviation unch
Profit Margin 1.52%
Beta 0.40

Growth Rates
YTD +4.35%
1-Year +0.64%
3-Year -24.16%
5-Year -6.50%
© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.